Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multipl...
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma
About this item
Full title
Author / Creator
Murakami, Satsuki , Ri, Masaki , Ito, Masato , Nakamura, Nobuhiko , Kasahara, Senji , Kitagawa, Junichi , Inagaki, Yuichiro , Kuroda, Junya , Yoshimitsu, Makoto , Okamoto, Akinao , Fukuhara, Noriko , Taji, Hirofumi , Iida, Hiroatsu , Nagai, Hirokazu , Hanamura, Ichiro , Tsujimura, Hideki , Okura, Miyuki , Kurata, Mio , Kuwatsuka, Yachiyo , Atsuta, Yoshiko and Iida, Shinsuke
Publisher
Singapore: Springer Nature Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Nature Singapore
Subjects
More information
Scope and Contents
Contents
The BLd regimen, which is a triplet regimen of bortezomib (Bor), lenalidomide (Len), and dexamethasone (Dex), is effective against newly diagnosed multiple myeloma (NDMM). However, non-hematological toxicities, such as peripheral neuropathy (PN), often hamper long-term continuation of the regimen, particularly in older adult patients. In this study...
Alternative Titles
Full title
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma
Authors, Artists and Contributors
Author / Creator
Ri, Masaki
Ito, Masato
Nakamura, Nobuhiko
Kasahara, Senji
Kitagawa, Junichi
Inagaki, Yuichiro
Kuroda, Junya
Yoshimitsu, Makoto
Okamoto, Akinao
Fukuhara, Noriko
Taji, Hirofumi
Iida, Hiroatsu
Nagai, Hirokazu
Hanamura, Ichiro
Tsujimura, Hideki
Okura, Miyuki
Kurata, Mio
Kuwatsuka, Yachiyo
Atsuta, Yoshiko
Iida, Shinsuke
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2890041788
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2890041788
Other Identifiers
ISSN
0925-5710,1865-3774
E-ISSN
1865-3774
DOI
10.1007/s12185-022-03379-9
